Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock (IABPSHOCK)

This study has been completed.

Sponsor:

Information provided by:

Martin-Luther-Universität Halle-Wittenberg

ClinicalTrials.gov Identifier:

NCT00469248

First received: May 3, 2007

Last updated: NA

Last verified: April 2007

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	June 2004
Estimated Primary Completion Date:	No date given

No publications provided by Martin-Luther-Universität Halle-Wittenberg

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Prondzinsky R, Unverzagt S, Lemm H, Wegener N, Heinroth K, Buerke U, Fiedler M, Thiery J, Haerting J, Werdan K, Buerke M. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β. Med Klin Intensivmed Notfmed. 2012 Sep;107(6):476-84. Epub 2012 Jul 20.

Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012 Apr;37(4):378-84.

To Top